If You Invested in HUTCHMED (China) Limited (HMDCF)
Looking for the current price? See the HMDCF quote & overviewWhat $1,000 or $10,000 in HMDCF Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Aug 31, 2022 |
|---|---|---|---|---|
| $1,000 | $590 -41% | — | — | $871 -13% |
| $10,000 | $5,902 -41% | — | — | $8,710 -13% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for HMDCF$1,000 Investment Over Time
HMDCF vs S&P 500Year-by-Year Returns
HMDCF annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2022 | $2.48 | $3.00 | +21.0% | +21.0% |
| 2023 | $3.45 | $3.81 | +10.6% | +53.8% |
| 2024 | $3.21 | $3.21 | +0.0% | +29.2% |
| 2025 | $3.66 | $3.66 | +0.0% | +47.6% |
| 2026 | $3.19 | $2.16 | -32.2% | -12.9% |
About HUTCHMED (China) Limited
Healthcare · OTC Link
HUTCHMED (China) Limited (HMDCF) is a foreign private issuer that reports to the U.S. Securities and Exchange Commission under the Securities Exchange Act of 1934. The company files its reports under cover of Form 20-F, which is the standard annual reporting format for many non-U.S. companies whose securities trade in U.S. markets.
According to its SEC filings, the registrant’s English name is HUTCHMED (China) Limited. The company is associated with Hong Kong, as indicated by the address reference to Hong Kong in its filings. As a foreign issuer, HUTCHMED (China) Limited provides disclosures tailored to investors who follow international companies through U.S. reporting standards.
The company uses Form 6-K to furnish current reports on significant corporate developments. These reports can include press releases, presentations, and other information that HUTCHMED (China) Limited chooses to make available to investors and regulators between its annual Form 20-F filings. This structure allows investors to follow both periodic and event-driven disclosures from the company.
Business and reporting profile
HUTCHMED (China) Limited is identified in SEC documents as a foreign issuer under the Exchange Act. It indicates that it files annual reports on Form 20-F rather than Form 40-F, which is used by certain Canadian issuers. This distinction helps investors understand the reporting framework and accounting disclosures that apply to the company.
The company’s use of Form 6-K to share a press release relating to an R&D updates presentation demonstrates that it provides ongoing information about its activities through SEC-furnished materials. While the detailed business description, industry classification, and specific operating segments are not described in the available data, the filings confirm that HUTCHMED (China) Limited maintains a presence in the U.S. regulatory reporting system as a foreign private issuer.
Key SEC reporting practices
From the available filing, HUTCHMED (China) Limited:
- Files annual reports under Form 20-F.
- Uses Form 6-K to furnish current reports and press releases.
- Provides English-language disclosures for U.S. investors.
- References Hong Kong in its corporate address information.
Investors researching HMDCF can use these filings to understand how the company communicates material information and how often it updates the market through SEC channels.
Use of Form 6-K and exhibits
In one Form 6-K, HUTCHMED (China) Limited includes an exhibit index listing a press release relating to an R&D updates presentation. This indicates that the company may use Form 6-K to share information on research and development-related updates and other corporate communications with the market. The exhibit structure allows investors to locate specific documents, such as press releases, that are associated with each current report.
Because the available information is limited to the structure of a specific Form 6-K and the company’s status as a foreign issuer, more detailed operational and industry information would need to be obtained from additional filings or disclosures beyond what is provided here.
How investors can use this information
For investors and researchers, the SEC reporting pattern of HUTCHMED (China) Limited helps frame where to look for key disclosures. The Form 20-F is typically the primary source for annual financial and business information, while Form 6-K filings can provide interim updates, press releases, and event-related materials such as presentations. Understanding that HMDCF corresponds to HUTCHMED (China) Limited, a foreign issuer reporting via Form 20-F and 6-K, is a starting point for deeper due diligence using the company’s broader SEC filing history.
Frequently Asked Questions
HUTCHMED (China) Limited investment returns
How much would $1,000 invested in HUTCHMED (China) Limited be worth today?
If you invested $1,000 in HUTCHMED (China) Limited (HMDCF) 1 years ago on 2025-09-30, your investment would be worth $590 today, representing a -41.0% total return, growing at a compounded rate of -56.4% per year (CAGR).
Has HUTCHMED (China) Limited outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare HMDCF performance over available time periods.
What is HUTCHMED (China) Limited's average annual return?
The compound annual growth rate (CAGR) of HMDCF over the past 1 years is -56.4%, growing at a compounded rate each year. Individual years vary significantly — HMDCF's best recent year was 2022 (+21.0%) and worst was 2026 (-32.2%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
